Latest filing published 09 Jan 2026 for NewAmsterdam Pharma Co N.V.. Read the official filing
No signal scores available.
All filings by Hilde Johanna van der Kamp on record concern NewAmsterdam Pharma Co N.V. Between 7 January 2025 and 7 January 2026, the trades on record add up to 2 filings.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 9 January 2026, reports a share grant in NewAmsterdam Pharma Co N.V. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations